“…Such NSAIDs-based drug delivery systems (DDS) with non-biodegradable polymers support are to be avoided as they need frequent replacements that affect a patient’s comfort and can cause additional trauma to the new epithelial tissue formed, the risk of secondary infection being very high [ 7 , 9 , 24 , 25 , 26 , 27 ]. Therefore, biodegradable polymers are considered to be ideal vehicles for drugs delivery [ 28 ], collagen being preferred due to its properties such as biodegradability, bioresorbability, biocompatibility, hemostasis ability, well-known structure, and reduced manufacturing cost [ 29 , 30 , 31 , 32 , 33 , 34 , 35 ]. The use of collagen as drug release support is however limited by its mechanical properties and resistance to in vivo enzymatic degradation, but these characteristics could be enhanced by chemical reaction using various crosslinkers such as glutaraldehyde [ 31 , 32 , 36 , 37 ], or by blending with other biopolymers.…”